Hogy Medical Co.,Ltd.

    Hogy Medical Co.,Ltd.

    TTSE:3593
    6,660.00
    JPY
    0.00
    (0.00%)
    105.15P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    1,051.96
    1,105.99
    1,120
    1,162.47
    1,175.52
    1,178.96
    1,203
    1,232.65
    1,207.47
    1,287.58
    1,607
    1,611.55
    1,750.4
    806.29
    Basic EPS, GAAP
    166.79
    179.03
    179.89
    187.87
    184.53
    168.04
    198.31
    183.05
    164.03
    152.99
    177.93
    115.57
    67.98
    44.18
    Free Cash Flow per Basic Share
    140.75
    226.84
    -122.58
    -285.31
    134.68
    137
    181.61
    5
    -22.69
    185.55
    320.9
    177.89
    279.43
    164.19
    Dividend per Share
    48.51
    53.44
    55.47
    57.51
    59.73
    61.79
    64.06
    65.68
    67.61
    69.84
    69.96
    77.98
    81.98
    40.02
    Book Value per Share
    2,021.49
    2,147.11
    2,271.54
    2,402.03
    2,534.63
    2,644.28
    2,851.56
    2,991.46
    3,085.24
    3,348.53
    4,050.99
    3,086.47
    2,847.78
    2,673.96
    Tangible Book Value per Share
    2,161.38
    2,338.47
    2,567.49
    2,682
    2,759.54
    2,909.17
    2,914.24
    3,033.28
    3,109.32
    2,746.78
    3,415.88
    3,529.05
    3,307.5
    3,106.41
    Basic Weighted Avg Shares
    31
    31
    31
    31
    31
    31
    30
    30
    30
    29
    24
    24
    22
    24
    Sales/Revenue/Turnover
    33,094
    34,793
    35,233
    36,568
    36,859
    36,918
    36,658
    37,232
    36,504
    36,778
    38,981
    39,100
    39,138
    19,564
    Operating Margin (%)
    24.52
    25.14
    24.14
    24.02
    20.19
    14.28
    11.96
    14.26
    15.43
    16.68
    17.02
    10.66
    9.74
    9.17
    Depreciation Expense
    2,971
    2,865
    2,708
    3,376
    4,409
    6,235
    5,631
    5,283
    4,549
    4,115
    3,617
    6,607
    5,741
    3,312
    Net Income, GAAP
    5,247
    5,632
    5,659
    5,910
    5,786
    5,262
    6,043
    5,529
    4,959
    4,370
    4,316
    2,804
    1,520
    1,072
    Effective Tax Rate (%)
    37.18
    36.6
    34.79
    32.39
    31.3
    30.61
    28.9
    28.93
    29.47
    31.04
    30.76
    31.46
    48.16
    35.68
    Profit Margin (%)
    15.85
    16.19
    16.06
    16.16
    15.7
    14.25
    16.48
    14.85
    13.58
    11.88
    11.07
    7.17
    3.88
    5.48
    Working Capital
    33,726
    34,201
    26,243
    24,512
    26,932
    34,053
    34,921
    32,869
    33,732
    25,942
    29,156
    34,784
    33,819
    36,028
    LT Debt
    - -
    - -
    - -
    - -
    508
    399
    285
    175
    - -
    7,667
    5,668
    3,669
    11,670
    12,669
    Total Equity
    69,601
    75,379
    83,300
    87,609
    89,628
    94,063
    91,403
    93,920
    95,951
    79,994
    83,678
    86,118
    74,331
    75,798
    Return on Invested Capital (%)
    7.42
    7.46
    6.58
    6.56
    5.61
    3.89
    3.28
    3.97
    4.11
    4.49
    4.97
    3.08
    2.18
    1.25
    Return on Capital (%)
    8.45
    8.55
    7.78
    7.65
    7.34
    6.4
    7.02
    6.2
    5.4
    4.42
    4.1
    3.01
    1.97
    1.34
    Return on Common Equity (%)
    8.5
    8.59
    8.14
    8.04
    7.46
    6.49
    7.12
    6.24
    5.4
    4.63
    4.45
    3.24
    2.19
    1.54

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Mar'24
    Jun'25
    Sep'25
    ST Debt
    2,154
    - -
    1,999
    LT Borrowings
    3,669
    - -
    12,669
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    24
    - -
    22
    Market Capitalization
    89,737
    94,913
    112,722

    Working Capital

    JPY

    •

    in mil. unless spec.
    Mar'24
    Jun'25
    Sep'25
    Total Current Assets
    43,025
    - -
    45,332
    Cash, Cash Equivalents & STI
    19,419
    - -
    22,664
    Accounts Receivable, Net
    8,458
    - -
    7,690
    Inventories
    9,455
    - -
    9,979
    Total Current Liabilities
    8,241
    - -
    9,304
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    2,154
    - -
    1,999
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -0.83%
    -4.13%
    -13.69%
    Free Cash Flow
    -146.08%
    -275.96%
    44.76%
    Net Income, GAAP
    -10.46%
    -20.85%
    -45.79%
    Sales/Revenue/Turnover
    1.08%
    1.04%
    0.1%
    Total Cash Common Dividend
    0.71%
    -1.19%
    -3.12%

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    9,679
    9,857
    10,218
    9,346
    39,100
    2025
    - -
    - -
    - -
    - -
    39,138
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    36.53
    - -
    - -
    - -
    115.57
    2025
    - -
    - -
    - -
    - -
    67.98
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    17.97
    - -
    - -
    - -
    77.98
    2025
    - -
    - -
    - -
    - -
    81.98
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business